Literature DB >> 24877885

The up-regulation of endothelin-1 and down-regulation of miRNA-125a-5p, -155, and -199a/b-3p in human atherosclerotic coronary artery.

Li Hao1, Xiao-Guang Wang1, Jian-Ding Cheng1, Sheng-Zhong You1, Su-Hua Ma1, Xia Zhong1, Li Quan2, Bin Luo3.   

Abstract

BACKGROUND: Previous studies have reported important roles of endothelin-1 (ET-1) and angiotensin II (Ang II) in the pathogenesis of atherosclerosis. However, the expression of these two proteins and the underlying mechanisms in human atherosclerotic coronary arteries are largely unknown.
METHODS: We examined the expression of ET-1 and Ang II in pericardial fluid and coronary arteries from 25 individuals (n = 25) using enzyme-linked immuno sorbent assay (ELISA) and immunohistochemistry. Twelve patients died from acute coronary syndrome were classified as atherosclerotic plaque group (AP group) (n = 12), while 13 patients died from other causes were classified as non-AP group (n = 13). Meanwhile, we performed reverse transcription-polymerase chain reaction (RT-PCR) to measure the expression of six microRNAs targeting ET-1 in formalin-fixed, paraffin-embedded coronary arteries.
RESULTS: Our data showed that ET-1 was significantly higher in both pericardial fluid and coronary arteries from AP group. However, Ang II showed no significant difference in pericardial fluid between the two groups, while it was even significantly lower in coronary arteries from AP group. Besides, miR-125a-5p, miR-155, and miR-199a/b-3p, which suppressed the expression of ET-1, were down-regulated in the coronary arteries from AP group.
CONCLUSION: The up-regulation of ET-1, regulated by miR-125a-5p, miR-155, and miR-199a/b-3p, indicated that ET-1 played an important role in human coronary atherosclerosis.
SUMMARY: We focused on the human coronary arteries with atherosclerotic plaques. The expression of ET-1, as well as its upstream miRNAs, was determined. Unlike any of previous study regarding miRNAs expression, we could exclude the discrepancy of artery-bed-specific miRNA expression. Besides, our data indicated, to some degree, that ET-1 might play a more vital role than Ang II in coronary atherosclerosis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiotensin II; Coronary atherosclerosis; Endothelin-1; MicroRNAs

Mesh:

Substances:

Year:  2014        PMID: 24877885     DOI: 10.1016/j.carpath.2014.03.009

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  24 in total

1.  Expression profiles of microRNAs in oxidized low-density lipoprotein-stimulated RAW 264.7 cells.

Authors:  Xiaokai Li; Siyuan Feng; Yi Luo; Keren Long; Zhenghao Lin; Jideng Ma; Anan Jiang; Long Jin; Qianzi Tang; Mingzhou Li; Xun Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-01-10       Impact factor: 2.416

2.  Insufficient sleep is associated with a pro-atherogenic circulating microRNA signature.

Authors:  Jamie G Hijmans; Ma'ayan Levy; Vinicius Garcia; Grace M Lincenberg; Kyle J Diehl; Jared J Greiner; Brian L Stauffer; Christopher A DeSouza
Journal:  Exp Physiol       Date:  2019-04-30       Impact factor: 2.969

3.  MiR-199a-3p Restrains Foaming and Inflammation by Regulating RUNX1 in Macrophages.

Authors:  Mingxin Liu; Yiming Cao; Yu Hu; Zhe Zhang; Sitong Ji; Linyang Shi; Guizhou Tao
Journal:  Mol Biotechnol       Date:  2022-04-18       Impact factor: 2.860

4.  Up-regulated microRNA-199b-3p represses the apoptosis of cerebral microvascular endothelial cells in ischemic stroke through down-regulation of MAPK/ERK/EGR1 axis.

Authors:  Ya-Xiong Yong; Hua Yang; Jia Lian; Xiao-Wei Xu; Ke Han; Ming-Yi Hu; Hua-Cheng Wang; Lie-Min Zhou
Journal:  Cell Cycle       Date:  2019-07-10       Impact factor: 5.173

5.  Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval Project.

Authors:  Bernd Frank; Liana Ariza; Heidrun Lamparter; Vera Grossmann; Jürgen H Prochaska; Alexander Ullmann; Florentina Kindler; Gerhard Weisser; Ulrich Walter; Karl J Lackner; Christine Espinola-Klein; Thomas Münzel; Stavros V Konstantinides; Philipp S Wild
Journal:  BMJ Open       Date:  2015-07-01       Impact factor: 2.692

6.  Metabolic interactions between hyperhomocysteinemia and endothelin-1 among Tunisian patients with acute coronary diseases.

Authors:  Abdelkader Chalghoum; Yosri Noichri; Ines Karkouch; Azza Dandana; Bruno Baudin; Guieder Jeridi; Salima Ferchichi; Abdelhédi Miled
Journal:  Biol Res       Date:  2015-06-24       Impact factor: 5.612

Review 7.  Epigenetic modulation in the treatment of atherosclerotic disease.

Authors:  Mikaela M Byrne; Ross T Murphy; Anthony W Ryan
Journal:  Front Genet       Date:  2014-10-28       Impact factor: 4.599

8.  Optimized Collection Protocol for Plasma MicroRNA Measurement in Patients with Cardiovascular Disease.

Authors:  Chi-Sheng Wu; Fen-Chiung Lin; Shu-Jen Chen; Yung-Lung Chen; Wen-Jung Chung; Cheng-I Cheng
Journal:  Biomed Res Int       Date:  2016-09-20       Impact factor: 3.411

9.  Relationship between the A(8002)G intronic polymorphism of pre-pro-endothelin-1 gene and the endothelin-1 concentration among Tunisian coronary patients.

Authors:  Abdelkader Chalghoum; Yosri Noichri; Azza Dandana; Sana Azaiez; Bruno Baudin; Gouider Jeridi; Abdelhédi Miled; Salima Ferchichi
Journal:  BMC Cardiovasc Disord       Date:  2015-11-16       Impact factor: 2.298

10.  Circulating microRNA profile in patients with membranous obstruction of the inferior vena cava.

Authors:  Gui-Xiang Sun; Yong Su; Ying Li; Ya-Feng Zhang; Li-Chun Xu; Mao-Heng Zu; Shui-Ping Huang; Jin-Peng Zhang; Zhao-Jun Lu
Journal:  Exp Ther Med       Date:  2016-01-12       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.